Tryptamine Therapeutics Limited
TYPTF
$0.01
$0.00-6.67%
OTC PK
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 11/30/2023 | |
|---|---|---|---|---|---|
| Net Income | -3.49M | -- | -- | -- | -3.56M |
| Total Depreciation and Amortization | 35.00K | -- | -- | -- | -- |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 105.60K | -- | -- | -- | 507.60K |
| Change in Net Operating Assets | -1.71M | -- | -- | -- | 365.90K |
| Cash from Operations | -5.06M | -- | -- | -- | -2.68M |
| Capital Expenditure | -85.10K | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -2.60K | -- | -- | -- | -6.00K |
| Cash from Investing | -87.80K | -- | -- | -- | -6.00K |
| Total Debt Issued | -- | -- | -- | -- | 4.81M |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 6.00M | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -403.40K | -- | -- | -- | -- |
| Cash from Financing | 3.62M | -- | -- | -- | 3.54M |
| Foreign Exchange rate Adjustments | 6.40K | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -1.53M | -- | -- | -- | 849.60K |